HomeRTGN • OTCMKTS
add
RetinalGenix Technologies Inc
Previous close
$3.65
Year range
$0.25 - $6.36
Market cap
67.61M USD
Avg Volume
33.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 586.35K | -72.66% |
Net income | -587.26K | 72.63% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -586.32K | 72.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.71K | -92.63% |
Total assets | 11.93K | -76.38% |
Total liabilities | 1.68M | 7.04% |
Total equity | -1.67M | — |
Shares outstanding | 18.52M | — |
Price to book | -40.56 | — |
Return on assets | -10,908.44% | — |
Return on capital | 143.50% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -587.26K | 72.63% |
Cash from operations | -187.22K | -14.29% |
Cash from investing | — | — |
Cash from financing | 184.87K | -13.69% |
Net change in cash | -2.35K | -104.66% |
Free cash flow | 29.07K | — |
About
Founded
2017
Headquarters
Website
